A novel quantitative prognostic model for initially diagnosed non-small cell lung cancer with brain metastases

Kvale PA, Simoff M, Prakash UB. Lung cancer. Palliative Care Chest. 2003;123(1 Suppl):284S-311S.

PubMed  Google Scholar 

Pesce GA, Klingbiel D, Ribi K, Zouhair A, von Moos R, Schlaeppi M, Caspar CB, Fischer N, Anchisi S, Peters S, Cathomas R, Bernhard J, Kotrubczik NM, D’Addario G, Pilop C, Weber DC, Bodis S, Pless M, Mayer M, Stupp R. Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03). Eur J Cancer. 2012;48(3):377–84.

PubMed  Article  Google Scholar 

Ricciardi S, de Marinis F. Multimodality management of non-small cell lung cancer patients with brain metastases. Curr Opin Oncol. 2010;22(2):86–93.

CAS  PubMed  Article  Google Scholar 

Gaspar LE, Scott C, Murray K, Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys. 2000;47(4):1001–6.

CAS  PubMed  Article  Google Scholar 

Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37(4):745–51.

CAS  PubMed  Article  Google Scholar 

Weltman E, Salvajoli JV, Brandt RA, de Morais HR, Prisco FE, Cruz JC, de Oliveira BS, Wajsbrot DB. Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys. 2000;46(5):1155–61.

CAS  PubMed  Article  Google Scholar 

Lorenzoni J, Devriendt D, Massager N, David P, Ruiz S, Vanderlinden B, Van Houtte P, Brotchi J, Levivier M. Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys. 2004;60(1):218–24.

PubMed  Article  Google Scholar 

Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 2008;70(2):510–4.

PubMed  Article  Google Scholar 

Dinglin XX, Ma SX, Wang F, Li DL, Liang JZ, Chen XR, Liu Q, Zeng YD, Chen LK. Establishment of an adjusted prognosis analysis model for initially diagnosed non-small-cell lung cancer with brain metastases from sun Yat-Sen University Cancer Center. Clin Lung Cancer. 2017;18(3):e179–86.

PubMed  Article  Google Scholar 

Vandenbrouck Y, Christiany D, Combes F, Loux V, Brun V. Bioinformatics tools and workflow to select blood biomarkers for early cancer diagnosis: an application to pancreatic cancer. Proteomics. 2019;19(21–22): e1800489.

PubMed  Article  CAS  Google Scholar 

Dong J. Signaling pathways implicated in carbon nanotube-induced lung inflammation. Front Immunol. 2020;11: 552613.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Jafri SH, Shi R, Mills G. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. BMC Cancer. 2013;13:158.

PubMed  PubMed Central  Article  Google Scholar 

Nakagawa T, Toyazaki T, Chiba N, Ueda Y, Gotoh M. Prognostic value of body mass index and change in body weight in postoperative outcomes of lung cancer surgery. Interact Cardiovasc Thorac Surg. 2016;23(4):560–6.

PubMed  Article  Google Scholar 

Polanski J, Jankowska-Polanska B, Uchmanowicz I, Chabowski M, Janczak D, Mazur G, Rosinczuk J. Malnutrition and quality of life in patients with non-small-cell lung cancer. Adv Exp Med Biol. 2017;1021:15–26.

PubMed  Article  CAS  Google Scholar 

Li W, Qu Y, Wen F, Yu R, He X, Jia H, Liu H, Yu H. Prognostic nutritional index and systemic immune-inflammation index are prognostic biomarkers for non-small-cell lung cancer brain metastases. Biomark Med. 2021;15(13):1071–84.

CAS  PubMed  Article  Google Scholar 

Berardi R, Rinaldi S, Santoni M, Newsom-Davis T, Tiberi M, Morgese F, Caramanti M, Savini A, Ferrini C, Torniai M, Fiordoliva I, Bower M, Cascinu S. Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy. Oncotarget. 2016;7(18):26916–24.

PubMed  PubMed Central  Article  Google Scholar 

Yilmaz A, Mirili C, Bilici M, Tekin SB. A novel predictor in patients with gastrointestinal stromal tumors: systemic immune-inflammation index (SII). J Buon. 2019;24(5):2127–35.

PubMed  Google Scholar 

He X, Li JP, Liu XH, Zhang JP, Zeng QY, Chen H, Chen SL. Prognostic value of C-reactive protein/albumin ratio in predicting overall survival of Chinese cervical cancer patients overall survival: comparison among various inflammation based factors. J Cancer. 2018;9(10):1877–84.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Kamarudin AN, Cox T, Kolamunnage-Dona R. Time-dependent ROC curve analysis in medical research: current methods and applications. BMC Med Res Methodol. 2017;17(1):53.

PubMed  PubMed Central  Article  Google Scholar 

Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565–74.

PubMed  PubMed Central  Article  Google Scholar 

Fitzgerald M, Saville BR, Lewis RJ. Decision curve analysis. JAMA. 2015;313(4):409–10.

CAS  PubMed  Article  Google Scholar 

Tian MX, Liu WR, Wang H, Zhou YF, Jin L, Jiang XF, Tao CY, Tang Z, Zhou PY, Fang Y, Qu WF, Ding ZB, Peng YF, Dai Z, Qiu SJ, Zhou J, Lau WY, Fan J, Shi YH. Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma. BMC Med. 2019;17(1):106.

PubMed  PubMed Central  Article  Google Scholar 

Xu WH, Wu J, Wang J, Wan FN, Wang HK, Cao DL, Qu YY, Zhang HL, Ye DW. Screening and identification of potential prognostic biomarkers in adrenocortical carcinoma. Front Genet. 2019;10:821.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Huang Y, Liu Z, He L, Chen X, Pan D, Ma Z, Liang C, Tian J, Liang C. Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer. Radiology. 2016;281(3):947–57.

PubMed  Article  Google Scholar 

Enders F, Geisenberger C, Jungk C, Bermejo JL, Warta R, von Deimling A, Herold-Mende C, Unterberg A. Prognostic factors and long-term survival in surgically treated brain metastases from non-small cell lung cancer. Clin Neurol Neurosurg. 2016;142:72–80.

PubMed  Article  Google Scholar 

Sierzega M, Lenart M, Rutkowska M, Surman M, Mytar B, Matyja A, Siedlar M, Kulig J. Preoperative neutrophil-lymphocyte and lymphocyte-monocyte ratios reflect immune cell population rearrangement in resectable pancreatic cancer. Ann Surg Oncol. 2017;24(3):808–15.

PubMed  Article  Google Scholar 

Salim DK, Mutlu H, Eryilmaz MK, Salim O, Musri FY, Tural D, Gunduz S, Coskun HS. Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer. Mol Clin Oncol. 2015;3(4):839–42.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Park YH, Yi HG, Lee MH, Kim CS, Lim JH. Prognostic value of the pretreatment advanced lung cancer inflammation index (ALI) in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy. Acta Haematol. 2017;137(2):76–85.

PubMed  Article  CAS  Google Scholar 

Gomperts BN, Spira A, Massion PP, Walser TC, Wistuba II, Minna JD, Dubinett SM. Evolving concepts in lung carcinogenesis. Semin Respir Crit Care Med. 2011;32(1):32–43.

PubMed  PubMed Central  Article  Google Scholar 

Tomasetti C, Vogelstein B. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science. 2015;347(6217):78–81.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Nakano Y, Yokohira M, Hashimoto N, Yamakawa K, Kishi S, Ninomiya F, Kanie S, Saoo K, Imaida K. Rat strain differences in levels and effects of chronic inflammation due to intratracheal instillation of quartz on lung tumorigenesis induced by DHPN. Exp Toxicol Pathol. 2014;66(8):391–401.

CAS  PubMed  Article  Google Scholar 

Zaynagetdinov R, Sherrill TP, Polosukhin VV, Han W, Ausborn JA, McLoed AG, McMahon FB, Gleaves LA, Degryse AL, Stathopoulos GT, Yull FE, Blackwell TS. A critical role for macrophages in promotion of urethane-induced lung carcinogenesis. J Immunol. 2011;187(11):5703–11.

CAS  PubMed  Article  Google Scholar 

Nakano-Narusawa Y, Yokohira M, Yamakawa K, Ye J, Tanimoto M, Wu L, Mukai Y, Imaida K, Matsuda Y. Relationship between lung carcinogenesis and chronic inflammation in rodents. Cancers (Basel). 2021;13(12):2910.

CAS  Article  Google Scholar 

Keohavong P, Peter DY. Pulmonary inflammation and KRAS mutation in lung cancer. Adv Exp Med Biol. 2021;1303:71–87.

CAS  PubMed  Article  Google Scholar 

Moldoveanu B, Otmishi P, Jani P, Walker J, Sarmiento X, Guardiola J, Saad M, Yu J. Inflammatory mechanisms in the lung. J Inflamm Res. 2009;2:1–11.

CAS  PubMed  Google Scholar 

Starzer AM, Steindl A, Mair MJ, Deischinger C, Simonovska A, Widhalm G, Gatterbauer B, Dieckmann K, Heller G, Preusser M, Berghoff AS. Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases. Br J Cancer. 2021;124(7):1294–300.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Warburg O. On respiratory impairment in cancer cells. Science. 1956;124(3215):269–70.

留言 (0)

沒有登入
gif